Skip to main content
TipRanks
Go Ultimate75% OFF

Milestone Pharmaceuticals (MIST) Q3 2022 Earnings Report

830 Followers

MIST Q3 2022 EPS Results

Actual EPS
-$0.34
Consensus EPS
-$0.41
Beat/Miss
Beat by +$0.07
One Year Ago EPS
-$0.34

MIST Q3 2022 Revenue Results

Actual Revenue
$1.50M
Expected Revenue
$0
Beat/Miss
Beat by +$1.50M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2022
Date
11/10/2022
Time
Before Open
Conference Call
Thursday, November 10, 2022
MIST Upcoming Earnings

Milestone Pharmaceuticals's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

MIST Earnings History

MIST earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.21--0.16――
Nov 13, 20262026 (Q3)-0.22-0.18-0.12-50.00% (-0.06)
Aug 12, 20262026 (Q2)-0.20-0.21-0.2-5.00% (-0.01)
May 13, 20262026 (Q1)0.19-0.20-0.3135.48% (+0.11)
Mar 20, 20262025 (Q4)-0.16-0.16-0.1915.79% (+0.03)
Nov 12, 20252025 (Q3)-0.16-0.12-0.1414.29% (+0.02)
Aug 12, 20252025 (Q2)-0.18-0.20-0.14-42.86% (-0.06)
May 14, 20252025 (Q1)-0.18-0.31-0.21-47.62% (-0.10)
Mar 13, 20252024 (Q4)-0.16-0.19-0.3240.63% (+0.13)
Nov 12, 20242024 (Q3)-0.16-0.14-0.3560.00% (+0.21)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed